Doctronic

Market position

Doctronic positions itself as a 24/7 "digital front door" to healthcare and as the world's most popular AI doctor. Its investor Lightspeed frames it as a consumer health platform combining autonomous triage with co-piloted physician treatment, differentiated from horizontal AI assistants such as ChatGPT that lack medical-specific accuracy safeguards and physician integration. The company contrasts itself with traditional telehealth providers including Teladoc, K Health and HealthTap, which begin with a human visit.

Unlike telehealth services that start with a clinician, Doctronic starts with an AI consultation that documents the case and escalates to a physician only when needed. It cites a study of 500 real-world urgent-care cases in which the AI and physicians agreed on the main diagnosis 81% of the time and on treatment plans 99.2% of the time with zero hallucinations, and in which the AI was judged superior four times more often in discordant cases, compared with base LLM clinical accuracy cited at 50-55%. Other stated differentiators are anonymous, account-free access, exclusive training on peer-reviewed medical literature, and physician oversight of AI guidelines.

Technology

Doctronic uses a multi-agent "collective intelligence" architecture described as more than 100 specialized AI agents that each take a clinical role — gathering history, analyzing findings and debating candidate diagnoses and treatments before reaching consensus. Board-certified physicians design, review and update the medical guidelines behind the system, and the AI is trained exclusively on peer-reviewed medical sources rather than general web content. Each encounter produces a structured SOAP note. The platform also maintains a centralized electronic medical record and a proprietary dataset linking symptoms, outcomes and evidence, and is built on HIPAA-aligned infrastructure.

Go-to-market

Direct-to-consumer acquisition through a free, anonymous web chat and iOS/Android apps, with conversion to paid $39 physician video visits; SEO-oriented condition and service content on the company site; employer benefit distribution; and partnerships with payers and health systems, including a partnership with Safe Harbor Health to serve more than 100,000 patients through its TOTAL Wellness Program.

U.S. adults aged 18 and over seeking urgent-care and primary-care guidance — including cold and flu symptoms, allergies, rashes, gastrointestinal issues, infections, headaches, medication questions and chronic condition management — particularly those facing long primary care wait times or lacking consistent access. International users can use the AI chat in English. The company also serves employers offering it as a benefit and, increasingly, payers, health systems and digital health partners.

Geography

Headquartered in New York. Physician video visits are available in all 50 U.S. states and Washington, D.C.; the AI chat is accessible internationally in English.

History

The company was founded in 2023 and launched a service that includes human clinicians in January 2025. In August 2025 it published what it described as the first large-scale validation of an autonomous AI doctor. It raised a $20 million Series A led by Lightspeed Venture Partners announced in September 2025, and a $40 million Series B led by Abstract and Lightspeed announced in March 2026, bringing total funding to $65 million across three rounds in under a year. Earlier in 2026 it launched a chatbot-based prescription renewal service described as a first in the U.S.

Risks & controversies

STAT reported that the company is preparing for its first FDA meeting amid safety concerns raised by experts, and that it launched a first-in-the-nation experiment to renew drug prescriptions via chatbot. The company itself notes that AI can make mistakes, advises users to review AI recommendations with a medical professional, and directs emergencies to 911; its clinicians cannot prescribe controlled substances or ADHD medications.